Skip to main content
Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc. — Investor Relations & Filings

Ticker · AXSM ISIN · US05464T1043 LEI · 549300EXGR0XLRJEIB95 US Manufacturing
Filings indexed 614 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country US United States of America
Listing US AXSM

About Axsome Therapeutics, Inc.

https://www.axsome.com/

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing and delivering novel therapies for the management of central nervous system (CNS) disorders. The company's portfolio includes commercialized products such as Auvelity® for major depressive disorder and Sunosi® for excessive daytime sleepiness in narcolepsy. Its clinical development pipeline targets other CNS conditions with limited treatment options, including Alzheimer's disease agitation, migraine, and fibromyalgia.

Recent filings

Filing Released Lang Actions
8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)
Regulatory Filings
2026-05-04 English
ARS - Axsome Therapeutics, Inc. (0001579428) (Filer)
Annual Report
2026-04-24 English
DEF 14A - Axsome Therapeutics, Inc. (0001579428) (Filer)
Proxy Solicitation & Information Statement
2026-04-24 English
8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)
Regulatory Filings
2026-04-01 English
4 - AXSOME THERAPEUTICS, INC. (0001579428) (Filer)
Director's Dealing
2026-02-27 English
4 - AXSOME THERAPEUTICS, INC. (0001579428) (Filer)
Director's Dealing
2026-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.